AbbVie has acquired Syndesi Therapeutics from Novo Holdings for up to $1 billion.
Source: https://www.pehub.com/abbvie-acquires-syndesi-for-1bn/
Powered by WPeMatico
Securities offered through Burch & Company, Inc. member FINRA/SiPC 4151 N Mulberry Drive, Suite 435 Kansas City, MO 64116
Apex Partners and Burch & Company are not affiliated. Any advisory services discussed on this site that are required to be performed by a registered broker-dealer shall be performed by Burch & Company, Inc., through its registered agents, Barry Harbour or Jim McCoy. Apex Partners is not registered as a broker or dealer and therefore does not perform services that involve securities.
Comments are closed.